Profile for Ionis Pharmaceuticals Inc. (IONS)

$ 61.04   -1.05 (-1.69%) Volume: 826.96k 4:00 PM EDT 13-Jul-2020
After Hours:  $ 61.20   0.16 (+0.26%) Volume: 98.71k 7:05 PM EDT 13-Jul-2020
Business Description:
Ionis Pharmaceuticals Inc is the RNA-targeted drug discovery and development company. Its broad pipeline consists of close to 32 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe, and rare diseases.
Address: 2855 Gazelle Court, Carlsbad, CA, USA, 92010
Telephone: +1 760 931-9200 Website:
Facsimile: +1 760 268-4922 Email: [email protected]
CEO: Brett P. Monia
Employees: 817 Market Cap: 8.5b
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 874015
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)